A case series of 12 colonic pseudolipomatosis from an endoscopy unit were reported in an endemic fashion within a year (incidence of 0.94%) when they changed the endoscopic disinfectant from 2% glutaraldehyde to peracetic acid to decrease the length of the endoscope reprocessing time. It was assumed that the finding was from chemical colitis secondary to residual disinfectant on the surface or channel of the endoscope. Another group described it as a "snow white sign" in which instantaneous effervescence and blanching were observed on the colonic mucosa when water was instilled in the colon; this was thought to be from the hydrogen peroxide and/or peracetic acid present in the water channel. In both series, all patients were asymptomatic after the procedures.
At endoscopy, it looks like focal leukoplakia, single or multiple, a few millimeters to a few centimeters in size, some confluent with normal mucosa in between. The diagnosis is confirmed by immunohistochemistry, which shows numerous optically empty vacuoles measuring 20 to 240 mm, displacing the adjacent lamina propria. These changes, suggestive of fat cells without nuclei or fat content, are thought to be iatrogenic (filled with air) in the absence of inflammation and dysplasia. In a study, colonic pseudolipomatosis was attributed to either abnormal stagnation of interstitial fluid or penetrance of gas from the crypts into the mucosa during colonoscopy. The differential diagnosis includes colonic pneumatosis, lymphangioma, and malakoplakia.
Spontaneous resolution after conservative management is seen within weeks. Therefore, its correct recognition should prevent unnecessary investigations and treatment. Proposed etiologies are still divided between barotrauma and chemical injury.
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